Key facts
- It has raised $30K; the latest was Seed Round in Feb 2026.
- Notable investors include StartX (US), Alchemist Accelerator, Matter (Consulting Services (B2B)), University Avenue Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Arithmedics
- ·The full record, as it builds
Funding rounds
No funding rounds for Arithmedics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arithmedics
Developer of healthcare administration software designed for interpreting and enhancing clinical documentation through data intelligence. The company's platform uses augmented analytics to analyze clinical notes in real time, suggest appropriate billing codes, explain coding decisions, minimize manual errors, identify and reduce potential claim denials, and learn from previous billing outcomes, enabling healthcare providers to streamline revenue cycle processes, improve coding accuracy, and reduce administrative overhead.
- Sector
- Healthcare
- HQ
- Cupertino, CA, United States
- Founded
- 2023
- Employees
- 6
- Website
- arithmedics.ai/
- Ownership
- Privately Held (backing)
Arithmedics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arithmedics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arithmedics in its N-PORT filings yet. We sweep new filings monthly.